In 2012, a study titled “Drug-induced gynecomastia: an evidence-based review.” was published that aimed to clarify which drugs cause gynecomastia, the development of breasts in men.

“Drugs are estimated to cause about 10 – 25% of all cases of gynecomastia. Over the course of several decades, multiple medications have been implicated in the development of gynecomastia mostly in the form of case reports and case series. However, these reports suffer from a multitude of deficiencies, including poor quality of evidence.”

So, the authors reviewed a number of studies that had reported associations between certain drugs and gynecomastia dating back to 1940 and assessed the “quality of evidence” used by those previous researchers to make the connections they did.

In the end, the authors state that “Most of the reported drug-gynecomastia associations were based on poor quality evidence. The drugs definitely associated with the onset of gynecomastia are spironolactone, cimetidine, ketoconazole, hGH, estrogens, hCG, anti-androgens, GnRH analogs and 5-α reductase inhibitors. Medications probably associated with gynecomastia include risperidone, verapamil, nifedipine, omeprazole, alkylating agents, HIV medications (efavirenz), anabolic steroids, alcohol and opioids.”

Due to the fact that Janssen Pharmaceuticals, Inc. failed time and again to warn users its Risperdal (risperidone) antipsychotic had been associated with male breast growth, a number of Risperdal lawsuits are currently being filed.

If you or a loved one used Risperdal and had gynecomastia, you may be entitled to significant financial compensation from the manufacturer.  For a free, no-obligation case consultation, contact our team of Risperdal lawyers at the information provided below.  We have the skills, resources, and experience required to win the justice you deserve.

Call today and see how we can help!

(855) 452 – 5529

Our Risperdal Lawsuit Information page is a great place to start if you have any questions about Risperdal.